Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 13.730
- -0.430-3.04%
Close Mar 18 16:00 ET
- 13.730
- 0.0000.00%
Post 20:01 ET
372.36MMarket Cap-4.58P/E (TTM)
14.371High13.390Low423.55KVolume13.920Open14.160Pre Close5.81MTurnover1.71%Turnover RatioLossP/E (Static)27.12MShares45.00052wk High1.55P/B340.97MFloat Cap12.75052wk Low--Dividend TTM24.83MShs Float129.710Historical High--Div YieldTTM6.93%Amplitude4.110Historical Low13.706Avg Price1Lot Size
About Arcturus Therapeutics Company
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Company Profile
SymbolARCT
Company NameArcturus Therapeutics
Listing DateMay 22, 2013
Founded2013
CEOMr. Joseph E. Payne
MarketNASDAQ
Employees176
Fiscal Year Ends12-31
Address10628 Science Center Drive,Suite 250
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-900-2660
Websitehttp://www.arcturusrx.com
Company Executives
- Name
- Position
- Salary
- Joseph E. Payne
- Director, President and Chief Executive Officer
- 4.89M
- Andrew H. Sassine
- Director, Chief Financial Officer and Principal Accounting Officer
- 2.18M
- Lance Kurata
- Chief Legal Officer
- 2.10M
- Dr. Padmanabh Chivukula
- Chief Scientific Officer and Chief Operating Officer
- 3.18M
- Dr. Moncef M. Slaoui, PhD
- Chairman of the Board
- --
- Dr. Jing L. Marantz, M.D.,PhD
- Independent Director
- 318.00K
- Dr. Edward W. Holmes
- Independent Director
- 325.50K
- Dr. Magda Marquet, PhD
- Independent Director
- 318.00K
- James F. Barlow
- Independent Director
- 330.50K
- Dr. John H. Markels, PhD
- Independent Director
- 320.50K
- Dr. Peter C. Farrell, A.M.,PhD
- Independent Director
- 328.00K
- Joseph Robert
- Controller
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.